The final, formatted version of the article will be published soon.
PERSPECTIVE article
Front. Public Health
Sec. Environmental Health and Exposome
Volume 12 - 2024 |
doi: 10.3389/fpubh.2024.1473222
Management of phthalates in Canada and beyond: can we do better to protect human health?
Provisionally accepted- 1 Division of Respiratory Medicine, Department of Medicine, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada
- 2 Norwegian Institute of Public Health (NIPH), Oslo, Oslo, Norway
- 3 Air Pollution Exposure Laboratory, Division of Respiratory Medicine, Department of Medicine, University of British Columbia, Vancouver, Canada
- 4 Legacy for Airway Health, Vancouver Coastal Health Research Institute, Vancouver, Canada
- 5 Department of Earth Sciences, Faculty of Arts and Science, University of Toronto, Toronto, Ontario, Canada
- 6 School of Environment, University of Toronto, Toronto, Canada
Ortho-phthalates (herein referred to as phthalates) are synthetic chemicals used in thousands of different everyday products and materials. Nearly ubiquitous environmental exposure is reflected by phthalate metabolites in the urine of almost all Canadians. However, phthalate exposure tends to be higher amongst people of low socioeconomic status and ethnic minorities. Substantial evidence shows that certain phthalates cause harm to human health, particularly developing fetuses and children.Governments vary in their approach to assessing and managing risks associated with phthalates. Canada continues to take a more permissive stance on phthalate regulations compared to the EU and some US states. We argue that the recent Canadian national risk assessment on phthalates does not appropriately reflect the growing evidence demonstrating harm to human health from phthalate exposure and does not adequately consider the evidence showing higher exposures faced by vulnerable populations. Canadians would benefit from adopting a more stringent regulatory approach to phthalates. Specifically, Canada should expand phthalate restrictions to apply to all consumer products, implement sunset dates towards eliminating the use of existing phthalates, and mandate publicly available evidence of no harm for phthalate alternatives. Canadian alignment on phthalate regulations with the EU and a growing number of US states could encourage other countries to follow suit.
Keywords: phthalates, Chemicals in products, Vulnerable Populations, child exposure/health, Endocrine discruptors, environmental justice, Risk Management, Chemical regulations
Received: 30 Jul 2024; Accepted: 24 Oct 2024.
Copyright: © 2024 Renwick, Kobach Bølling, Shellington, Rider, Diamond and Carlsten. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Anette Kobach Bølling, Norwegian Institute of Public Health (NIPH), Oslo, 0456, Oslo, Norway
Chris Rider, Air Pollution Exposure Laboratory, Division of Respiratory Medicine, Department of Medicine, University of British Columbia, Vancouver, Canada
Miriam L. Diamond, Department of Earth Sciences, Faculty of Arts and Science, University of Toronto, Toronto, M5S 3B1, Ontario, Canada
Chris Carlsten, Division of Respiratory Medicine, Department of Medicine, Faculty of Medicine, University of British Columbia, Vancouver, V5Z 1M9, British Columbia, Canada
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.